Coral Laboratories Stock Screener | Share Price & Fundamental Analysis
CORALAB
Pharmaceuticals
Share Price BSE
₹419.05
▼
-10.35 (-2.41%)
Track Coral Laboratories share price live with TickJournal's free stock screener.
Analyze Coral Laboratories share price history trends and compare 52-week high low
levels.
Calculate CORALAB stock fair value using fundamental analysis and view live share price charts.
Determine Coral Laboratories share intrinsic value and compare it with current CORALAB share price.
Record your Coral Laboratories trades in TickJournal's free trading journal and track your portfolio performance.
Coral Laboratories Market Cap
₹168.92 Cr.
CORALAB P/E Ratio (TTM)
15.00
EPS (TTM)
₹67.61
Dividend Yield
-
Debt to Equity
0.01
CORALAB 52 Week High
₹782.00
Coral Laboratories 52 Week Low
₹419.05
Operating Margin
18.00%
Profit Margin
17.17%
CORALAB Revenue (TTM)
₹99.00
EBITDA
₹25.00
Net Income
₹17.00
Total Assets
₹230.00
Total Equity
₹201.00
Coral Laboratories Share Price History - Stock Screener Chart
Screen CORALAB historical share price movements with interactive charts. Analyze price trends and patterns.
Coral Laboratories Company Profile - Fundamental Screener
Screen Coral Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for CORALAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE683E01017
Coral Laboratories Balance Sheet Screener
Screen CORALAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 230 | 206 | 174 | 190 | 168 | 144 | 136 | 140 | 131 | 90 |
| Current Assets | 177 | 154 | 124 | 131 | 129 | 96 | 84 | 72 | 74 | 65 |
| Fixed Assets | 23 | 24 | 25 | 24 | 21 | 23 | 23 | 22 | 18 | 18 |
| Liabilities | ||||||||||
| Total Liabilities | 230 | 206 | 174 | 190 | 168 | 144 | 136 | 140 | 131 | 90 |
| Current Liabilities | 3 | 3 | 8 | 8 | 3 | 4 | 4 | 4 | 4 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 201 | 178 | 155 | 156 | 137 | 116 | 114 | 116 | 109 | 70 |
| Share Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 198 | 174 | 151 | 153 | 133 | 112 | 110 | 113 | 106 | 67 |
Coral Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Coral Laboratories income statement and profit fundamentals.
Analyze CORALAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Coral Laboratories share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 99 | 124 | 90 | 85 | 80 | 100 | 77 | 96 | 97 | 99 | 80 | 62 |
| Expenses | 74 | 89 | 67 | 74 | 67 | 81 | 65 | 79 | 77 | 72 | 61 | 47 |
| EBITDA | 25 | 35 | 23 | 11 | 13 | 20 | 11 | 17 | 20 | 27 | 19 | 15 |
| Operating Profit % | 18.00% | 23.00% | 19.00% | 5.00% | 11.00% | 16.00% | 8.00% | 13.00% | 16.00% | 24.00% | 21.00% | 21.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 23 | 33 | 21 | 8 | 12 | 18 | 9 | 16 | 18 | 25 | 17 | 12 |
| Tax | 6 | 8 | 5 | 2 | 3 | 4 | 2 | 5 | 6 | 8 | 5 | 3 |
| Net Profit | 17 | 24 | 16 | 6 | 9 | 14 | 7 | 10 | 12 | 16 | 12 | 10 |
| EPS | 48.60 | 67.61 | 44.19 | 18.04 | 25.32 | 37.94 | 19.96 | 28.60 | 34.84 | 45.61 | 34.70 | 26.79 |
Coral Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen CORALAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -1 | -6 | 13 | 6 | 1 | -4 | -1 | 14 | 11 | 5 |
| Investing Activities | 0 | 1 | -3 | -6 | 0 | -2 | 3 | -13 | -10 | -3 |
| Financing Activities | 3 | 0 | -6 | 0 | 0 | 4 | -1 | -3 | 1 | 0 |
| Net Cash Flow | 1 | -4 | 4 | 0 | 1 | -2 | 1 | -2 | 2 | 2 |
Coral Laboratories Shareholding Pattern Screener
See Coral Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Coral Laboratories promoter holding and ownership changes for CORALAB on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.14% | 0.23% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 20.91% | 20.76% | 20.80% | 20.82% | 20.33% | 21.18% | 20.99% | 21.24% |
| Other Holding | 7.58% | 7.72% | 7.69% | 7.52% | 7.93% | 7.31% | 7.50% | 7.25% |
| Shareholder Count | 4,105 | 4,213 | 4,286 | 4,098 | 3,831 | 3,949 | 4,054 | 4,046 |
Coral Laboratories Share Dividend Screener - Share Yield Analysis
Check Coral Laboratories dividend history with payout and yield data.
View Coral Laboratories dividend details including ex-dates and amounts for CORALAB stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹2.00 | 2.04% |
| 2018-March | ₹2.00 | 0.63% |
| 2017-March | ₹5.00 | 0.84% |
| 2016-March | ₹0.00 | 0.00% |
Coral Laboratories Stock Index Membership
See which indices include Coral Laboratories stock.
Check CORALAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Coral Laboratories Market Events Screener - Corporate Actions
Get Coral Laboratories corporate actions including splits, bonuses, and buybacks.
Check Coral Laboratories stock events that may affect CORALAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 1.50 /share | -28.37% | ||
| Annual General Meeting | NA | 21.88% | ||
| Dividend | ₹ 2.00 /share | 23.19% | ||
| Annual General Meeting | NA | -5.28% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 0.41% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -3.21% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 4.18% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -8.05% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -2.11% |
Coral Laboratories Competitors Screener - Peer Comparison
Screen CORALAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 424,634 | 39.93 | 54,729 | 9.71% | 10,980 | 49.55 |
| Divis Laboratories | 172,860 | 69.20 | 9,712 | 18.67% | 2,191 | 56.33 |
| Torrent Pharmaceuticals | 129,151 | 60.10 | 11,539 | 6.99% | 1,911 | 61.47 |
| Cipla | 122,205 | 22.55 | 28,410 | 7.12% | 5,291 | 49.47 |
| Dr Reddys Laboratories | 107,114 | 18.60 | 33,741 | 16.73% | 5,725 | 60.05 |
| Lupin | 97,120 | 22.34 | 22,910 | 13.74% | 3,306 | 65.28 |
| Zydus Life Science | 92,392 | 18.40 | 23,511 | 18.55% | 4,615 | 40.07 |
| Mankind Pharma | 90,241 | 50.59 | 12,744 | 20.90% | 2,007 | 45.53 |
| Aurobindo Pharma | 71,119 | 20.79 | 32,346 | 9.43% | 3,484 | 59.88 |
| Alkem Laboratories | 67,243 | 27.59 | 13,458 | 3.70% | 2,216 | 49.80 |
Coral Laboratories Company Announcements - News Screener
Screen CORALAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-14 | Results - Financial Results For Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of The Board Meeting Held On November 14 2025 Pursuant To Regulation 30 (Read With Part A Of Schedule III) The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") | View |
| 2025-11-07 | Board Meeting Intimation for Notice Under Regulation 29(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-10-13 | Outcome Of The Board Meeting Held On October 13 2025 For Capacity Expansion At The Plant Located At Dehradun Corrigendum To Announcement Under Regulation 30 Of The SEBI (LODR) 2015 | View |
| 2025-10-13 | Intimation Regarding Capacity Addition Under Regulation 30 (Read With Part A Of Schedule III) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-10-13 | Board Meeting Outcome for Outcome Of The Board Meeting Held On October 13 2025 For Capacity Expansion At The Plant Located At Dehradun | View |
| 2025-10-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-26 | Combined Scrutinizer Report For Remote E-Voting And Voting At The AGM Carried Out For The 43Rd Annual General Meeting Of The Company Held On Friday September 26 2025. | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-25 | Board Meeting Outcome for Outcome Of The Board Meeting Held On September 25 2025 Pursuant To Regulation 30 (Read With Part A Of Schedule III) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-09-25 | Board Meeting Outcome for Outcome Of The Board Meeting Held On September 25 2025 Pursuant To Regulation 30 (Read With Part A Of Schedule III) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-09-24 | Closure of Trading Window | View |
| 2025-09-20 | Board Meeting Intimation for Notice Under Regulattion 29(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-09-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-03 | Notice Convening The 43Rd Annual General Meeting (AGM) And The Annual Report For Financial Year 2024-2025. | View |
| 2025-09-03 | Reg. 34 (1) Annual Report. | View |
| 2025-09-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-30 | Notice Of Book Closure | View |
| 2025-08-30 | Notice Of Book Closure & Record Date | View |
| 2025-08-30 | Notice Of Book Closure & Record Date | View |